Farzana Pashankar
Pediatric Hematology-Oncology · New Haven, CTNPI 1700860210
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,728 of the $2,103 with a category attached, or 82.2%.
Across 12 payments — averaging $175.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1K
- Novartis$995
Across 119 payments — averaging $4311.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$319K
- Merck$100K
- Novartis$25K
- Novartis Pharma AG$23K
- Incyte Corporation$16K
- Novo Nordisk AS$11K
- plus $18K from 3 others
What the payments were for
- Travel & lodging$1,72882%
- Food & beverage$37518%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric hematology-oncology providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Other pediatric hematology-oncology in New Haven
- Michael RechtNew Haven$334K
- Prasanna AnanthNew Haven$23K
- Asher MarksNew Haven$7K
- Sarah ChirnomasNew Haven$2K
- Juan VasquezNew Haven$209
- Salley PelsNew Haven$191
- Aron FlaggNew Haven$106
- Stephanie MassaroNew Haven$0
- Nina Kadan LottickNew Haven$0
- Natalie BezlerHartford$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.